Darlington Memorial Hospital
Darlington, Co Durham, dl3 6hxl, United Kingdom
NCT Number: NCT01250015
To establish whether provision of numerical data, framed as event rates and illustrated by pictograms, and including figures for all-cause mortality, affects subjects' attitudes to colorectal cancer (CRC) screening.
Design and Intervention. Randomised questionnaire and telephone study comparing the responses of a control group given the standard National Health Service (NHS) CRC screening information with the responses of an intervention group given the same information but enhanced with additional numerical and pictorial information.
Setting
Looking for future studies?
Notify Me60 year–70 year
All sexes
Observational
Darlington, Co Durham, dl3 6hxl, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 60 - 70
-
Exclusion criteria
Time frame: 1 year
The study compared the two groups' overall wish to be screened as recorded by questionnaire
Time frame: 1 year
The impact of each of the 6 summary points in the NHS information leaflet on the subject's desire to be screened depending on whether or not they were enhanced by numerical and pictorial information, the summary point that most influenced their decision on whether to be screened; and the views of the intervention group on the numerical and pictorial information provided
County Durham and Darlington NHS Foundation Trust
Other Gov
THE RESULTS OF A RANDOMISED CONTROLLED QUESTIONNAIRE-BASED TRIAL ON WHETHER PROVISION OF NUMERICAL AND PICTORIAL INFORMATION ON RISK AND BENEFIT AFFECTS THE UPTAKE OF COLORECTAL CANCER SCREENING?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06666556
Colonic Diseases, Colorectal Cancer Screening
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT06982053
Colonic Diseases, Colorectal Cancer Control and Prevention
Wuhan, China
View Trial DetailsNCT04683744
COVID-19, Colonic Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT03959696
Colonic Diseases, Colorectal Cancer Screening
Portland, Maine, United States
View Trial Details